| pubmed-article:2688540 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2688540 | lifeskim:mentions | umls-concept:C0017921 | lld:lifeskim |
| pubmed-article:2688540 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
| pubmed-article:2688540 | lifeskim:mentions | umls-concept:C1850620 | lld:lifeskim |
| pubmed-article:2688540 | lifeskim:mentions | umls-concept:C0027937 | lld:lifeskim |
| pubmed-article:2688540 | pubmed:issue | Pt 2 | lld:pubmed |
| pubmed-article:2688540 | pubmed:dateCreated | 1990-1-24 | lld:pubmed |
| pubmed-article:2688540 | pubmed:abstractText | The lysosomal storage disorder glycogenosis type II, caused by a deficiency of lysosomal alpha-glucosidase, is very heterogeneous in its clinical presentation. It has been suggested that this heterogeneity may be due to differential expression of neutral alpha-glucosidases. We have therefore analysed the activity of the major neutral alpha-glucosidases in cultured fibroblasts or muscle cells from 26 patients with glycogenosis type II. The results indicate that there is no correlation between the expression of neutral alpha-glucosidase isoenzymes and the clinical phenotype of this disease. | lld:pubmed |
| pubmed-article:2688540 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2688540 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2688540 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2688540 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2688540 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2688540 | pubmed:month | May | lld:pubmed |
| pubmed-article:2688540 | pubmed:issn | 0003-4800 | lld:pubmed |
| pubmed-article:2688540 | pubmed:author | pubmed-author:SwallowD MDM | lld:pubmed |
| pubmed-article:2688540 | pubmed:author | pubmed-author:ReuserA JAJ | lld:pubmed |
| pubmed-article:2688540 | pubmed:author | pubmed-author:KroosM AMA | lld:pubmed |
| pubmed-article:2688540 | pubmed:author | pubmed-author:Van der... | lld:pubmed |
| pubmed-article:2688540 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2688540 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:2688540 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2688540 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2688540 | pubmed:pagination | 185-92 | lld:pubmed |
| pubmed-article:2688540 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:meshHeading | pubmed-meshheading:2688540-... | lld:pubmed |
| pubmed-article:2688540 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2688540 | pubmed:articleTitle | An investigation of the possible influence of neutral alpha-glucosidases on the clinical heterogeneity of glycogenosis type II. | lld:pubmed |
| pubmed-article:2688540 | pubmed:affiliation | Department of Cell Biology and Genetics, Erasmus University Rotterdam, The Netherlands. | lld:pubmed |
| pubmed-article:2688540 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2688540 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2688540 | lld:pubmed |
